Efficacy and safety of rituximab in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis

Authors

Institutions

Publication Details

Journal
Expert Opinion on Biological Therapy
Published
2025-09-26
DOI
https://doi.org/10.1080/14712598.2025.2567868
Citations
1
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of rituximab in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis

O. Saidane, L. Rouached, L. Abdelmoula, Z. Zeineb et al.
1 citations
Expert Opinion on Biological Therapy
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
1.52
article

Efficacy and safety of rituximab in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis

O. Saidane, L. Rouached, L. Abdelmoula, Z. Zeineb, R. Tekaya, S. Bouden, A. Ben Tekaya, Dziri Chadli, Mahmoud Ines
article en
1 citations

Abstract

No abstract available for this paper.
Expert Opinion on Biological TherapyVol. 25(10)
Institut des Régions Arides (TN), Hôpital Charles-Nicolle (TN), Tunis El Manar University (TN)
Openalex Percentile: Top 14%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.